Uveitis and the menstrual cycle

Eye

Volumn 18, Issue 5, 2004, Pages 451-454

  Sanghvi, C ^a   Aziz, K ^a   Jones, N P ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

Acute anterior uveitis; Cyclical; Menstrual cycle; Oestrogen; Progesterone; Sex hormone

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OPEN STUDY; PROSPECTIVE STUDY; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; UVEITIS;

EID: 2942639662     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700713     Document Type: Article

References (29)

1. O'Connor GR. Factors related to the initiation and recurrence of uveitis. Am J Ophthalmol 1983; 96: 577-599.
2. Snyder DA, Tesler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1980; 90: 69-75.
3. Bang D, Chun YS, Haam IB, Lee ES, Lee S. The influence of pregnancy on Behcet's disease. Yonsei Med 1997; 38: 437-443.
4. Agarwal RK, Chan CC, Wiggert B, Caspi RR. Pregnancy ameliorates induction and expression of experimental autoimmune uveitis. J Immunol 1999; 162: 2648-2654.
5. Heaton JM. An ecologic approach to uveitis. Am J Ophthalmol 1964; 57: 122-128.
6. Tan KS. Premenstrual asthma: epidemiology, pathogenesis and treatment. Drugs 2001; 61: 2079-2086.
7. Rudge SR, Kowanko IC, Drury PL. Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid arthritis. Ann Rheum Dis 1983; 42: 425-430.
8. Stevens HP, Ostlere LS, Black CM, Jacobs HS, Rustin MH. Cyclical psoriatic arthritis responding to anti-oestrogen therapy. Br J Dermatol 1993; 129: 458-460.
9. Arnbjornsson E. Acute appendicitis risk in various phases of the menstrual cycle. Acta Chir Scand 1983; 149: 603-605.
10. Kramer P, Lubkin V, Potter W, Jacobs M, Labay G, Silverman P. Cyclic changes in conjunctival smears from menstruating females. Ophthalmology 1990; 97: 303-307.
11. Connor CG, Flockencier LL, Hall CW. The influence of gender on the ocular surface. J Am Optom Assoc 1999; 70: 182-186.
12. Kiely PM, Carney LG, Smith G. Menstrual cycle variations of corneal topography and thickness. Am J Optom Physiol Opt 1983; 60: 822-829.
13. Riss B, Binder S, Riss P, Kemeter P. Corneal sensitivity during the menstrual cycle. Br J Ophthalmol 1982; 66: 123-126.
14. Serrander A-M, Peek KE. Changes in contact lens comfort related to the menstrual cycle and menopause. A review of articles. J Am Optom Assoc 1993; 64: 162-166.
15. Coles N, Lubkin V, Kramer P, Jacobs M. Hormonal analysis of tears saliva and serum from normals and postmenopausal dry eyes. Invest Ophthalmol Vis Sci 1990; 31: (Suppl): 29-48.
16. Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 2000; 78: 146-153.
17. Southren AL, Altman K, Vittek J et al. Steroid metabolism in ocular tissues of the rabbit. Invest Ophthalmol Vis Sci 1976; 15: 222-228.
18. Starka L, Hampl R, Bicikova M, Obenberger J, Rozsival P, Rehak S. Identification and radioimmunologic estimation of sexual steroid hormones in aqueous humour and vitreous of rabbit eyes. Graefes Arch Clin Exp Ophthalmol 1984; 199: 261-266.
19. Suzuma I, Mandai M, Suzuma K, Kazuhiro I, Tojo SJ, Honda Y. Contribution of E-selectin to cellular infiltration during endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 1998; 39: 1620.
20. Miyamoto N, Mandai M, Suzuma I, Suzuma K, Kobayashi K, Honda Y. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J Immunol 1999; 163: 374-379.
21. Chao TC, Van-Alten PJ, Greager JA, Walter RJ. Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cell Immunol 1995; 160: 43-47.
22. Girasole G, Julka RL, Passeri G, Boswell S, Boder G, Williams DC et al. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992; 89: 883-889.
23. Stock JL, Coderre JA, McDonald B, Rosenwasser LJ. Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from postmenopausal women. J Clin Endocrinol Metab 1989; 68: 364-368.
24. Bell JA. Danazol, premenstrual tension, and uveitis. Arch Ophthalmol 1989; 107: 796.
25. Contreras JL, Smyth CA, Bilbao G, Young CJ, Thompson JA, Eck DE. 17beta-estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation 2002; 15: 1252-1259.
26. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90-119.
27. Grossi SG. Effect of estrogen supplementation on periodontal disease. Compend Con Educ Dent Suppl 1998; 22: S30-S36.
28. Cuchakovitvh M, Tchernitchin A, Gatica H, Wurgaft R, Valenzuela C, Cornejo E. Intraarticular progesterone: effects of a local treatment for rheumatoid arthritis. J Rheumatol 1988; 15: 561-565.
29. Beynon HL, Garbett ND, Barnes PJ. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet 1988; 8607: 370-372.